Literature DB >> 12141705

Management of scaphoid nonunion with avascular necrosis using 1, 2 intercompartmental supraretinacular arterial bone grafts.

Tsung-Ting Tsai1, En-Kai Chao, Yuan-Kun Tu, Alvin Chao-Yu Chen, Mel Shiuann-Sheng Lee, Steve Wen-Neng Ueng.   

Abstract

BACKGROUND: Poor reduction or neglect of an unstable carpal scaphoid fracture may lead to scaphoid nonunion or avascular necrosis. When pre-operative suggestion of avascular necrosis of the proximal pole is confirmed by intra-operative evaluation, conventional bone graft is not enough and a vascularized bone graft is strongly recommended.
METHODS: Five patients with nonunion of scaphoid fractures associated with avascular necrosis based on results of radiography and further confirmed by magnetic resonance images and intra-operative findings were operatively managed with 1, 2 intercompartmental supraretinacular arterial (1, 2 ICSRA) vascularized bone graft combined with supplemental cancellous bone grafts from the radius. Follow-up periods were at least 18 months. The functional outcomes and radiographs were analyzed.
RESULTS: In four of the five patients, the nonunion sites united within 4 months after surgery. The other patient had a superficial pin tract infection and bone healing was complete 6 months after the operation. The functional results were good in all five patients.
CONCLUSION: 1, 2 ICSRA is superficial to the retinaculum and runs directly into the bony tubercle. It is a proper pedicle of vascularized bone graft due to the ease of visibility and dissection. The functional results and union rates were satisfactory in our study.

Entities:  

Mesh:

Year:  2002        PMID: 12141705

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  9 in total

1.  New options for vascularized bone reconstruction in the upper extremity.

Authors:  Matthew T Houdek; Eric R Wagner; Cody C Wyles; George P Nanos; Steven L Moran
Journal:  Semin Plast Surg       Date:  2015-02       Impact factor: 2.314

2.  Scaphoid Nonunion With Poor Prognostic Factors: The Role of the Free Medial Femoral Condyle Vascularized Bone Graft.

Authors:  Tahseen Chaudhry; Lauren Uppal; Dominic Power; Michael Craigen; Simon Tan
Journal:  Hand (N Y)       Date:  2016-08-20

Review 3.  Prognostic factors in the treatment of carpal scaphoid non-unions.

Authors:  F Schuind; F Moungondo; W El Kazzi
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-11-28

4.  [Pedicled vascularized bone grafts from the dorsum of the distal radius for treatment of scaphoid nonunions].

Authors:  Michael Sauerbier; Allen T Bishop; Nina Ofer
Journal:  Oper Orthop Traumatol       Date:  2009-11       Impact factor: 1.154

5.  Vascularized bone grafts for the treatment of carpal bone pathology.

Authors:  Brian M Derby; Peter M Murray; Alexander Y Shin; Reuben A Bueno; Christophe L Mathoulin; Tim Ade; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2013-03

6.  Management of scaphoid nonunion with avascular necrosis using 1,2 intercompartmental supraretinacular arterial bone graft.

Authors:  Mohamad Dehghani; Mohamad Soltanmohamadi; Mohammad Ali Tahririan; Mehdi Moezi; Parnaz Daneshpajouhnejad; Abolghasem Zarezadeh
Journal:  Adv Biomed Res       Date:  2014-09-04

7.  Bone graft in the treatment of nonunion of the scaphoid with necrosis of the proximal pole: a literature review.

Authors:  Antônio Lourenço Severo; Marcelo Barreto Lemos; Osvandré Luiz Canfield Lech; Danilo Barreto Filho; Daniel Paulo Strack; Larissa Knapp Candido
Journal:  Rev Bras Ortop       Date:  2017-10-27

8.  Clinical and functional outcomes of vascularized bone graft in the treatment of scaphoid non-union.

Authors:  Alireza Rahimnia; Amir-Hossein Rahimnia; Abdolkarim Mobasher-Jannat
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

9.  Reconstruction of scaphoid nonunion fractures of the proximal one third with a vascularized bone graft from the distal radius.

Authors:  Frank Werdin; Patrick Jaminet; Beate Naegele; Matthias Pfau; Hans-Eberhard Schaller
Journal:  Eplasty       Date:  2014-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.